JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anjos, D. A.
Right arrow Articles by Camargo, E. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anjos, D. A.
Right arrow Articles by Camargo, E. E.
Journal of Nuclear Medicine Vol. 48 No. 5 764-770
© 2007 by Society of Nuclear Medicine

doi: 10.2967/jnumed.106.036350

Clinical Investigation

18F-FDG PET/CT Delayed Images After Diuretic for Restaging Invasive Bladder Cancer

Dalton A. Anjos1, Elba C.S.C. Etchebehere1, Celso D. Ramos1, Allan O. Santos1, César Albertotti2 and Edwaldo E. Camargo1

1 Division of Nuclear Medicine and PET/CT, Sírio-Libanês Hospital, São Paulo, Brazil; and 2 Division of Radiology, Sírio-Libanês Hospital, São Paulo, Brazil

Correspondence: For correspondence or reprints contact: Edwaldo E. Camargo, MD, PhD, Sírio-Libanês Hospital, Rua Adma Jafet, 91, Bela Vista–São Paulo, Brazil 01308-050. E-mail: edwaldo{at}mn-d.com

PET with 18F-FDG has been considered of limited value for detection of bladder cancer because of the urinary excretion of the tracer. The purpose of this study was to investigate the role of PET/CT in the detection and restaging of bladder cancer using furosemide and oral hydration to remove the excreted 18F-FDG from the bladder. Methods: Seventeen patients with bladder cancer (11 without cystectomy, 6 with total cystectomy and urinary diversion) underwent 18F-FDG PET/CT from head to the upper thighs 60 min after the intravenous injection of 370 MBq of 18F-FDG. Additional pelvic images were acquired 1 h after the intravenous injection of furosemide and oral hydration. PET/CT findings were confirmed by MRI, cystoscopy, or biopsy. Results: PET/CT was able to detect bladder lesions in 6 of 11 patients who had not undergone cystectomy. These images changed the PET/CT final reading in 7 patients: Recurrent bladder lesions were detected in 6 patients, pelvic lymph node metastases in 2 patients, and prostate metastasis in 1. This technique overcame the difficulties posed by the urinary excretion of 18F-FDG. Hypermetabolic lesions could be easily detected by PET and precisely localized in the bladder wall, pelvic lymph nodes, or prostate by CT. Seven of 17 patients (41%) were upstaged only after delayed pelvic images. Conclusion: Detection of locally recurrent or residual bladder tumors can be dramatically improved using 18F-FDG PET/CT with delayed images after a diuretic and oral hydration.

Key Words: bladder cancer • 18F-FDG • PET/CT • furosemide • oral hydration

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2007 48: 11a-12a. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.